Pfizer PE Ratio 2006-2019 | PFE

Current and historical p/e ratio for Pfizer (PFE) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Pfizer PE ratio as of October 18, 2019 is 11.88.
Pfizer PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-10-18 36.46 16.65
2019-06-30 43.32 $2.19 19.78
2019-03-31 42.47 $1.95 21.78
2018-12-31 43.28 $1.86 23.27
2018-09-30 43.36 $3.95 10.98
2018-06-30 35.39 $3.73 9.49
2018-03-31 34.29 $3.59 9.55
2017-12-31 34.68 $3.51 9.88
2017-09-30 33.87 $1.62 20.91
2017-06-30 31.56 $1.36 23.21
2017-03-31 31.84 $1.18 26.98
2016-12-31 29.92 $1.16 25.80
2016-09-30 30.90 $1.13 27.34
2016-06-30 31.85 $1.26 25.28
2016-03-31 26.57 $1.35 19.68
2015-12-31 28.65 $1.24 23.10
2015-09-30 27.65 $1.33 20.79
2015-06-30 29.28 $1.41 20.77
2015-03-31 30.13 $1.44 20.93
2014-12-31 26.75 $1.42 18.84
2014-09-30 25.17 $1.62 15.54
2014-06-30 25.04 $1.59 15.75
2014-03-31 26.86 $3.12 8.61
2013-12-31 25.40 $3.14 8.09
2013-09-30 23.64 $3.60 6.57
2013-06-30 22.86 $3.64 6.28
2013-03-31 23.36 $2.09 11.18
2012-12-31 20.12 $1.95 10.32
2012-09-30 19.76 $1.29 15.32
2012-06-30 18.12 $1.34 13.52
2012-03-31 17.67 $1.24 14.25
2011-12-31 16.71 $1.28 13.06
2011-09-30 13.52 $1.45 9.32
2011-06-30 15.58 $1.08 14.43
2011-03-31 15.21 $1.06 14.35
2010-12-31 12.98 $1.03 12.60
2010-09-30 12.60 $0.77 16.36
2010-06-30 10.35 $1.09 9.49
2010-03-31 12.32 $1.12 11.00
2009-12-31 12.94 $1.27 10.19
2009-09-30 11.66 $1.21 9.64
2009-06-30 10.46 $1.12 9.34
2009-03-31 9.39 $1.19 7.89
2008-12-31 11.95 $1.20 9.96
2008-09-30 12.21 $1.58 7.73
2008-06-30 11.38 $1.35 8.43
2008-03-31 13.42 $1.12 11.98
2007-12-31 14.37 $1.19 12.08
2007-09-30 15.26 $2.09 7.30
2007-06-30 15.78 $2.44 6.47
2007-03-31 15.43 $2.59 5.96
2006-12-31 15.65 $2.67 5.86
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $201.662B $53.647B
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Pfizer's Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. is headquartered in New York.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $359.375B 15.53
Roche Holding AG (RHHBY) Switzerland $250.381B 0.00
Merck (MRK) United States $214.559B 17.64
Novartis AG (NVS) Switzerland $199.914B 17.20
Novo Nordisk (NVO) Denmark $124.746B 22.04
Sanofi (SNY) France $116.442B 14.31
AstraZeneca (AZN) United Kingdom $115.787B 22.40
AbbVie (ABBV) United States $111.093B 8.90
GlaxoSmithKline (GSK) United Kingdom $105.929B 13.31
Eli Lilly (LLY) United States $104.711B 19.54
Bristol-Myers Squibb (BMY) United States $85.747B 12.16
Bayer (BAYRY) Germany $68.188B 9.93
H Lundbeck (HLUYY) Denmark $6.714B 9.69